Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory regulatory crackdown

Karnataka FDA Spurious Drug Racket Crackdown

Analysis based on 26 articles · First reported Sep 12, 2026 · Last updated Sep 24, 2026

Sentiment
-20
Attention
4
Articles
26
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The crackdown on counterfeit medicines may negatively impact Pfizer's reputation and sales in India, though the company's proactive cooperation could mitigate long-term damage. The broader pharmaceutical supply chain in India — Karnataka faces increased regulatory scrutiny, potentially affecting smaller distributors and retailers.

pharmaceuticals healthcare

The India — Karnataka Food Safety and Drugs Administration (FDA) uncovered a large-scale spurious drug racket following an August 18, 2026 raid at a farmhouse in Kurubarakeranahalli, Bidadi, India — Bengaluru South district. Authorities seized spurious drugs, machinery, and printing materials worth approximately Rs 5.05 crore, including 5,640 vials of CEFIAVIGENT 2.5 Injection and 1,531 vials of HIZLAM Injectables. The operation involved repacking low-cost medicines into new vials and relabelling them as expensive imported medicines, including products resembling Pfizer brands. The FDA cancelled 16 drug licences and suspended eight others, including the licence of Pfizer Ltd's C&F depot in Nelamangala. A Special Investigation Team (SIT) is probing the supply chain, which reportedly reached over 90 hospitals and clinics in India — Bengaluru. Pharmacy owner Veeresh Kumar Jain was arrested, and more than 15 medical representatives are under scrutiny. The alleged kingpin, Prashant, remains absconding. Pfizer stated that patient safety is its top priority and that it has been cooperating with authorities, removing affected batches from the market. Health Minister U. T. Khader vowed action against those involved regardless of status.

90 Veeresh Kumar Jain arrested
85 India — Bengaluru arrested pharmacy owner Veeresh Kumar Jain
80 Vibra Healthcare raided
80 India — Karnataka suspended drug licences
77 India — Karnataka cancelled drug licences
75 India — Karnataka suspended Pfizer licence Pfizer
70 Prashant ran counterfeit network
70 Pfizer removed batches from market
70 India — Karnataka suspended licences Med Pharma
65 India — Bengaluru seized counterfeit medicines
65 India — Karnataka seized spurious drugs
60 India — Bengaluru searched locations
60 India — Karnataka registered criminal case
60 India — Karnataka suspended licences Surya Speciality Hospital
+ 14 more actions View on Dashboard
loc
India — Karnataka's FDA led the crackdown, cancelling and suspending licences to protect public health. The state's regulatory actions aim to restore confidence in its pharmaceutical supply chain.
Importance 90.0 Sentiment 10.0
stock
Pfizer's brand was counterfeited, leading to suspension of its C&F depot licence and removal of affected batches. The company is cooperating with authorities to protect patient safety and its reputation.
Importance 85.0 Sentiment -30.0
loc
India — Bengaluru is the epicenter of the counterfeit drug distribution, with over 90 hospitals and clinics under scrutiny. The city's healthcare system faces reputational risks.
Importance 80.0 Sentiment -10.0
per
Arrested pharmacy owner allegedly involved in storing and distributing counterfeit medicines. His arrest is a key development in the investigation.
Importance 70.0 Sentiment -50.0
priv
The pharmacy served as a storage and distribution point for suspected counterfeit medicines. Its owner was arrested, and operations are under investigation.
Importance 65.0 Sentiment -60.0
per
Identified as the alleged kingpin of the racket, currently absconding. His capture is crucial for dismantling the network.
Importance 60.0 Sentiment -40.0
cnt
India faces reputational risk to its pharmaceutical sector and healthcare system from the large-scale counterfeit drug racket.
Importance 40.0 Sentiment -10.0
per
India — Karnataka Health Minister vowed action against those involved, emphasizing the government's commitment to public health.
Importance 40.0 Sentiment 5.0
per
Joint Commissioner of Police heading the SIT, leading the investigation into the counterfeit drug network.
Importance 35.0 Sentiment 0.0
per
Additional Drug Controller who stated that Pfizer depot's business transactions were stopped pending further orders.
Importance 30.0 Sentiment 0.0
loc
India — Haryana was among the states searched by the SIT as part of the interstate investigation into the counterfeit drug network.
Importance 20.0 Sentiment -5.0
loc
India — Himachal Pradesh was among the states searched by the SIT as part of the interstate investigation into the counterfeit drug network.
Importance 20.0 Sentiment -5.0
loc
India — Tamil Nadu was among the states searched by the SIT as part of the interstate investigation into the counterfeit drug network.
Importance 20.0 Sentiment -5.0
loc
India — Maharashtra was among the states searched by the SIT as part of the interstate investigation into the counterfeit drug network.
Importance 20.0 Sentiment -5.0
priv
One of the eight establishments whose licences were suspended by the India — Karnataka FDA for alleged involvement in the spurious drug distribution.
Importance 20.0 Sentiment -20.0
+ 6 more entities View on Dashboard
Pfizer related ↔ India
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.